Ono Pharma Foundation announces the start of the eighth year of the annual Breakthrough Science Initiative Awards Program (Ono Initiative) in the United States and Canada. Proposals from Principal Investigators will be considered for high-risk and high-reward science research projects which have the potential to lead to science discoveries/solutions and, based on further research, to breakthrough treatments for patients. The 
program information and FAQ are attached.
Target research of Chemical Biology is not specified by the Ono Initiative. For 2024, subjects of interest include but are not limited to below. Ono Pharma continues to welcome projects outside of these subjects.
- Modulating interactome and cell/tissue crosstalk with chemical induced proximity
- Manipulating biomolecular condensates and protein quality control systems
- Deep understanding and emerging applications of chemical glycobiology
- New concepts of drug delivery and localization to tissue/cell/organelle
Each selected project/PI will receive:
- Annual funding of $300,000/year for up to 3 years totalling a maximum of $900,000 for the normal term of a research project
- Up to an additional 15% ($45,000) per year of the funding to be used for indirect costs
- The total amount of the three-year grant would be up to $1,035,000
If you are interested in exploring this opportunity, please send Deanna Scarcella (des4016@med.cornell.edu) a NON-CONFIDENTIAL one-page overview of the proposed research collaboration for review by Mon, Jan 29, 2024. Institutions are allowed to nominate up to two researchers. We will ensure the project meets the Ono Pharma areas of interest and will notify the PI’s who are chosen to upload their submission to the Ono Pharma portal by the Thursday, February 15 due date.